Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
05/15/1997 | WO1997007209A3 Receptor |
05/15/1997 | WO1997006259A3 Resistance against wilt inducing fungi |
05/15/1997 | WO1997003635A3 P16 expression constructs and their application in cancer therapy |
05/15/1997 | WO1997001640A3 Vaccines against hepatitis c |
05/15/1997 | WO1997001576A3 Phenyl peptides, method for preparing same, and pharmaceutical compositions containing said peptides |
05/15/1997 | WO1996032480A3 METHODS AND COMPOSITIONS FOR DETERMINING HER-2/neu EXPRESSION |
05/15/1997 | DE19534763C1 FMR1-verwandtes Protein FMR1-related protein |
05/15/1997 | CA2237183A1 Huntingtin-associated protein |
05/15/1997 | CA2237114A1 Autoantigens |
05/15/1997 | CA2235631A1 Neuropeptide y-y5 receptor |
05/15/1997 | CA2235226A1 Peptides which enhance transport across tissues and methods of identifying and using the same |
05/15/1997 | CA2234810A1 Blackcurrant promoters and genes |
05/15/1997 | CA2234685A1 Peptides which enhance transport across tissues and methods of identifying and using the same |
05/15/1997 | CA2234683A1 A method for expressing phosphorylated recombinant human beta-casein in a bacterial system |
05/15/1997 | CA2232736A1 Commercial production of avidin in plants |
05/14/1997 | EP0773441A1 Molecules that home to a selected organ or tissue in vivo and methods of identifying same |
05/14/1997 | EP0773296A1 Secretory signal gene and expression vector having the same |
05/14/1997 | EP0773295A2 DNA-based vaccination of fish by immersion |
05/14/1997 | EP0773294A2 Efficient directional genetic cloning system |
05/14/1997 | EP0773293A2 Genetically engineered tumour cell lines and their use in the screening of antitumour-compositions |
05/14/1997 | EP0773291A2 Brain-specific adapter molecule, gene thereof, and antibody thereto |
05/14/1997 | EP0773290A2 Novel LDL receptor analog protein and the gene coding therefor |
05/14/1997 | EP0773289A2 Asialoglycoprotein receptor derivatives and their use |
05/14/1997 | EP0773030A1 Method of purifying necrotoxin produced by bordetella and toxoid |
05/14/1997 | EP0772776A1 Superparamagnetic particles, process for their production and their use |
05/14/1997 | EP0772774A1 Determination of a specific immunoglobulin using multiple antigens |
05/14/1997 | EP0772773A1 Src SH3 BINDING PEPTIDES AND METHODS OF ISOLATING AND USING SAME |
05/14/1997 | EP0772688A1 Sv-40 derived dna constructs comprising exogenous dna sequences |
05/14/1997 | EP0772681A1 Identification of a human cytomegalovirus gene involved in down-regulation of mhc class i heavy chain expression |
05/14/1997 | EP0772680A1 A polynucleotide herpes virus vaccine |
05/14/1997 | EP0772679A1 Schistosoma protein and uses thereof |
05/14/1997 | EP0772677A1 T cell activation |
05/14/1997 | EP0772634A1 Monoclonal antibodies specific for an epitope of a particular subclass or form of phosphorylated tau, hybridomas secreting them, antigen recognition of these antibodies and their applications |
05/14/1997 | EP0772633A1 Complexes for use in the diagnosis of vascular diseases |
05/14/1997 | EP0772632A2 T cell stimulating protein of pestivirus |
05/14/1997 | EP0772631A1 Processes for the purification of human recombinant decorin and the detection of guanidinium ions |
05/14/1997 | EP0772629A1 T cell epitopes of rye grass pollen allergen |
05/14/1997 | EP0772627A1 Production of biologically active recombinant neurotrophic protein |
05/14/1997 | EP0772626A1 Isolated nucleic acid sequence coding for a tumor rejection antigen presented by hla-a2 |
05/14/1997 | EP0772624A1 Interleukin-15 |
05/14/1997 | EP0772616A1 Hydrophilic metal complexes |
05/14/1997 | EP0772466A1 Compositions and methods for a bioartificial extracellular matrix |
05/14/1997 | EP0772460A1 Radiolabeled compounds for thrombus imaging |
05/14/1997 | EP0772455A2 Intracellular expression of carboxypeptidase g2 in enzyme prodrug therapy |
05/14/1997 | EP0772449A1 Pharmaceutical compositions comprising a chimaeric tnf binding protein |
05/14/1997 | EP0772448A1 CYCLIC ANALOGS OF PTH AND PTHrP |
05/14/1997 | EP0772437A1 Compositions and methods for delivery of genetic material |
05/14/1997 | EP0772435A1 Controlled release of metal cation-stabilized interferon |
05/14/1997 | EP0772404A1 Production of collagen in the milk of transgenic mammals |
05/14/1997 | EP0677111B1 Novel proteinaceous particles |
05/14/1997 | EP0644894B1 Peptide for stimulation of cytotoxic t lymphocytes specific for hepatitis c virus |
05/14/1997 | EP0644778B1 TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING |
05/14/1997 | EP0615453B1 Anti-cancer immunotherapeutic vector constructs |
05/14/1997 | EP0495131B1 Agent for preventing and treating hepatitis |
05/14/1997 | EP0441947B1 Neurotrophin-3, a novel neurotrophic factor related to nerve growth factor and brain derived neurotrophic factor |
05/14/1997 | CN1149889A Isolated nucleic acid molecule with codes for tumor rejection antigen precursor and uses thereof |
05/14/1997 | CN1149888A 流感疫苗 Influenza vaccination |
05/14/1997 | CN1149887A Compounds and methods for stimulation and enhancement of protective immune responses and IL-12 production |
05/14/1997 | CN1149833A Acylated enol derivatives as prodrugs of elastase inhibitors |
05/13/1997 | US5629470 Mono and dicotyledon plants are genetic engeneered with bacterio-opsin gene |
05/13/1997 | US5629469 Peptide virgiferin and variations; recombinant dna molecule with nucleic acid sequence encoding peptide; transgenic plant with foreign gene encoding peptide; combatting insects with peptide; host cell transformed with vector as described |
05/13/1997 | US5629414 Dna molecule coding for surface antigen of toxoplama gondii, vaccines |
05/13/1997 | US5629408 Immunochemical isolation of in vivo advanced glycosylation endproducts |
05/13/1997 | US5629407 DNA encoding an 18 KD CDK6 inhibiting protein and antibodies thereto |
05/13/1997 | US5629291 Methods of modulating fibronectin extracellular matrix assembly |
05/13/1997 | US5629288 Lipopeptide derivatives, a process for their preparation and their use |
05/13/1997 | US5629283 Granulocyte-macrophage colony-stimulating factor receptor and derivatives thereof |
05/13/1997 | US5629205 Promoters for gene expression |
05/13/1997 | US5629204 Peptide related to human programmed cell death and DNA encoding it |
05/13/1997 | US5629198 Porphyrin derivative |
05/13/1997 | US5629193 Paraoxonase |
05/13/1997 | US5629192 ETS1 gene: a human tumor suppressor gene |
05/13/1997 | US5629182 Obtained by cloning of chromosomal or plasmid dna of resistant bacterial strain |
05/13/1997 | US5629176 Dna construct comprising dna sequence encoding the variant; recombinant expression vector comprising the construct; host cell containing the construct or vector; culture process for making the variant; pharmaceutical comprising the variant |
05/13/1997 | US5629175 Molecular farming |
05/13/1997 | US5629174 Dna, rna |
05/13/1997 | US5629173 Methods of use of serine protease variants having peptide ligase activity |
05/13/1997 | US5629172 Ubiquitin molecule is cleavage site |
05/13/1997 | US5629167 Detection of antibodies against Chlamydia trachomatis pgp3 antigen in patient sera by enzyme-linked immunosorbent assay |
05/13/1997 | US5629166 Cancer diagnosis |
05/13/1997 | US5629165 Calpastatins, detection of neurodegenerative conditions such as alzheimer*s disease by reaction with antibody |
05/13/1997 | US5629163 Calcineurin inhibitory compounds and anchoring protein |
05/13/1997 | US5629162 Method of identifying agents which modulate ICAM-3 binding to LFA-1 |
05/13/1997 | US5629161 Use of human papillomavirus gene derived peptides for diagnosis |
05/13/1997 | US5629160 Diagnostic assay for inhibitor of tissue-type and urokinase-type plasminogen activators, and gene coding for the inhibitor |
05/13/1997 | US5629155 High-affinity oligonucleotide ligands to immunoglobulin E (IgE) |
05/13/1997 | US5629152 Synthetic polypeptides with double helical structure, binding to dna and rna strands, contain azetidine ring |
05/13/1997 | US5629146 Method for detection of human papillomavirus (HPV) for diagnostic purposes |
05/13/1997 | US5628996 Method for inhibiting the viability of Pseudomonas aeruginosa with cross-reactive and cross-protective monoclonal antibodies |
05/13/1997 | US5628995 Control of Ostrinia |
05/13/1997 | US5628994 Vibrio cholerae strain CVD103Hgr, method of making same, and vaccines derived therefrom |
05/13/1997 | US5628979 Reagent for tumor imaging and therapy |
05/09/1997 | WO1997016728A1 FORMATION AND USE OF PRION PROTEIN (PrP) COMPLEXES |
05/09/1997 | WO1997016557A1 TREATMENT OF TUMOURS BY ADOPTIVE TRANSFER OF CD44v-SPECIFIC CYTOTOXIC T-LYMPHOCYTES |
05/09/1997 | WO1997016550A1 Polypeptide fragments derived from the obese gene product |
05/09/1997 | WO1997016549A2 Molecular cloning and characterization of molecules related to relaxin and the insulin family of ligands |
05/09/1997 | WO1997016548A1 NEUROGENIC DIFFERENTIATION (NeuroD) GENES AND PROTEINS |
05/09/1997 | WO1997016539A1 Recombinant sendai virus |
05/09/1997 | WO1997016538A1 (-)-strand rna virus vector having autonomously replicating activity |
05/09/1997 | WO1997016535A2 METHODS FOR USE OF Mpl LIGANDS WITH PRIMITIVE HUMAN STEM CELLS |